45 related articles for article (PubMed ID: 20730428)
1. Effects of
Wu PL; Ling XC; Kang EY; Chen KJ; Wang NK; Liu L; Chen YP; Hwang YS; Lai CC; Yang SF; Wu WC
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430677
[TBL] [Abstract][Full Text] [Related]
2. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
3. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9.
Wang W; Li D; Xiang L; Lv M; Tao L; Ni T; Deng J; Gu X; Masatara S; Liu Y; Zhou Y
Cell Adh Migr; 2019 Dec; 13(1):273-284. PubMed ID: 31293204
[TBL] [Abstract][Full Text] [Related]
4. Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder.
Singh H; Jadhav S; Samani D; Nain S
Mediators Inflamm; 2019; 2019():8278095. PubMed ID: 31275061
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of annexin A7 decreases proliferation, migration, and invasion of gastric cancer cells by reducing matrix metalloproteinase 1 and 9 expression.
Yuan HF; Li Y; Ye WH; Liu Y; Zhang ZD; Tan BB; Fan LQ; Zhao Q; Wang D; Jia N; Hao YJ
Am J Transl Res; 2019; 11(5):2754-2764. PubMed ID: 31217851
[TBL] [Abstract][Full Text] [Related]
6. TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer.
Wang W; Zhang Y; Liu M; Wang Y; Yang T; Li D; Ding F; Bai G; Li Q
Sci Rep; 2018 Jun; 8(1):9629. PubMed ID: 29941993
[TBL] [Abstract][Full Text] [Related]
7. Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis.
Yang Y; Xiong Y; Li J; Wu C; Jiang J
Onco Targets Ther; 2016; 9():6801-6808. PubMed ID: 27843330
[TBL] [Abstract][Full Text] [Related]
8. Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.
Wu Z; Jiang P; Zulqarnain H; Gao H; Zhang W
Onco Targets Ther; 2015; 8():861-9. PubMed ID: 25945057
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.
Gurgel DC; Valença-Junior JT; Dornelas CA; Vieira RB; Maia-Filho JT; Lima-Junior RC; Ribeiro RA; Almeida PR
Pathol Oncol Res; 2015 Jan; 21(1):73-81. PubMed ID: 24800696
[TBL] [Abstract][Full Text] [Related]
10. Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.
Stetler-Stevenson WG; Gavil NV
Connect Tissue Res; 2014; 55(1):13-9. PubMed ID: 24437600
[TBL] [Abstract][Full Text] [Related]
11. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.
Li X; Qu L; Zhong Y; Zhao Y; Chen H; Daru L
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1433-47. PubMed ID: 23644699
[TBL] [Abstract][Full Text] [Related]
12. The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse.
Skorupski P; Jankiewicz K; Miotła P; Marczak M; Kulik-Rechberger B; Rechberger T
Int Urogynecol J; 2013 Jun; 24(6):1033-8. PubMed ID: 23108733
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.
Langers AM; Verspaget HW; Hommes DW; Sier CF
World J Gastrointest Oncol; 2011 Jun; 3(6):79-98. PubMed ID: 21731908
[TBL] [Abstract][Full Text] [Related]
14. Genotyping gastric cancer.
Spiliotis J
World J Surg; 2011 Aug; 35(8):1933-4; author reply 1935. PubMed ID: 21373953
[No Abstract] [Full Text] [Related]
15. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
Alakus H; Afriani N; Warnecke-Eberz U; Bollschweiler E; Fetzner U; Drebber U; Metzger R; Hölscher AH; Mönig SP
World J Surg; 2010 Dec; 34(12):2853-9. PubMed ID: 20730428
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
Kubben FJ; Sier CF; Meijer MJ; van den Berg M; van der Reijden JJ; Griffioen G; van de Velde CJ; Lamers CB; Verspaget HW
Br J Cancer; 2006 Sep; 95(6):744-51. PubMed ID: 16940985
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.
Wu CY; Wu MS; Chen YJ; Chen CJ; Chen HP; Shun CT; Chen GH; Huang SP; Lin JT
Eur J Cancer; 2007 Mar; 43(4):799-808. PubMed ID: 17236757
[TBL] [Abstract][Full Text] [Related]
18. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
19. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
